Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/20/2008WO2008064259B1 Solid dispersion composition comprising fluvastatin
11/20/2008WO2008062453B1 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form
11/20/2008WO2008061078A3 Matrix-embedded compositions having organic acids and fatty acids
11/20/2008WO2008035376A3 A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
11/20/2008WO2008030473A3 Process for forming nanoparticles by micellization of blocky copolymers in subcritical and supercritical solvents
11/20/2008WO2008029372A3 Device for the controlled release of a predefined quantity of a substance
11/20/2008WO2008022309A3 Polyconjugates for in vivo delivery of polynucleotides
11/20/2008WO2008022128A3 Transdermal delivery of meptazinol
11/20/2008WO2008016984A3 Polysaccharide vaccine and uses thereof
11/20/2008WO2007140315A8 System and method for delivering an agglomeration of solid beads and cement to the interior of a bone in order to form an implant within the bone
11/20/2008WO2007127837A3 Microspheroidal-controlled release of biomolecules
11/20/2008WO2007127172A3 Layered bio-adhesive compositions and uses thereof
11/20/2008WO2007120616A3 Wound dressings with anti-microbial and zinc-containing agents
11/20/2008WO2007106597A3 Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
11/20/2008WO2007103775A3 Biomaterials having nanoscale layers and coatings
11/20/2008WO2007103557A3 Coating capsules with active pharmaceutical ingredients
11/20/2008WO2007095524A3 Passive time released solute treatment
11/20/2008WO2007075408A3 Effervescent compositions for triptans
11/20/2008US20080288627 Storage network and method for storage network device mapping
11/20/2008US20080287922 User Interface for Delivery System Providing Graphical Programming of Profile
11/20/2008US20080287853 Method and system for producing dressing products of polymer fibres useful for covering moist wounds
11/20/2008US20080287553 Pharmaceutical compositions comprising peranhydrocyclodextrin
11/20/2008US20080287502 Transdermal Administration of Proton Pump Inhibitors
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287470 Presentation of an Antiviral Pharmaceutical Composition
11/20/2008US20080287456 Oral Therapeutic Compound Delivery System
11/20/2008US20080287417 Pharmaceutical compositions comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
11/20/2008US20080287387 Method for Producing Sterile Polynucleotide Based Medicaments
11/20/2008US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
11/20/2008US20080286414 Drink Comprising a Combination of Fish Oil and Probiotics
11/20/2008US20080286377 disodium pamidronate or etidronate antiresorptive agent having a particle-size distribution same or less than that of polymethyl methacrylate bone-cement to provide even distribution of anti-resorptive particles throughout a polymerized bone-cement matrix after polymerization; a bone cement monomer
11/20/2008US20080286376 Dry hemostatic compositions and methods for their preparation
11/20/2008US20080286375 capable of releasing a protein drug continuously over a long period of time without initial burst release; dissolving a protein drug in H2o to obtain a water phase; dissolving sucrose acetate isobutyrate and a biodegradable polymer in an organic solvent to obtain an oil phase, emulsifying
11/20/2008US20080286374 Hollow nano-particles and method thereof
11/20/2008US20080286373 ziprasidone, ziprasidone hcl; mono, di or triglycerides of C12-24 fatty acids, mono, or diesters of c12-c24 fatty acid and polyoxyethylene glycol, vitamin E tocopherol-succinic acid-polyethyleneglycol; sodium lauryl sulfate as anionic surfactant; hydroxyalkylalkyl cellulose; improved bioavailability;
11/20/2008US20080286372 Therapeutic compositions for targeted vessel delivery
11/20/2008US20080286371 highly ordered nanostructured mesoporous silica, having size pores of 2 to 50 nm and antigens of several natures, encapsulated by the particles of mesoporous silica, which act as immunization adjuvants
11/20/2008US20080286370 Nanoscale Particles Used as Contrasting Agents in Magnetic Resonance Imaging
11/20/2008US20080286369 water soluble particles include e.g. those with a crystalline core of D,L-valine and a coating of insulin or a crystalline core of L-glycine and a coating of antitrypsin; for pulmonary delivery; coprecipitation
11/20/2008US20080286368 administered sublingually in combination with a bio/mucoadhesion promoting compound (e.g. hydroxypropyl cellulose) in a manner giving rise to pharmacologically effective plasma levels of zolpidam, morphine, sufentanyl etc.within a short time after administration to treat pain, insomnia, diabetes etc
11/20/2008US20080286366 mammal blood platelet containing polyethyleneimine ( PEI) based nanoparticles (prepared by incubating PEI with green fluorescent protein (GFP) plasmid DNA) containing an active agent such as antibacterial, antiviral agent, blood coagulation protein, gene etc. drug delivery to sites of vascular injury
11/20/2008US20080286365 Method For Producing Solid-Lipid Composite Drug Particles
11/20/2008US20080286364 External dermatologic preparation
11/20/2008US20080286363 (R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one maleate; 3-[(Cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide (glycopyrrolate), and a glucocorticosteroids
11/20/2008US20080286362 mixture of non-aggregated isooctyltrimethoxysilane modified silica nanoparticle and solid bulk material in the form of a powder, containing a drug; free flowing; use in inhalation device
11/20/2008US20080286361 deliverying a therapeutic agent (DNA, CFTR genes, peptide, antibody etc. ) contained in targeting particles (e.g. magnetite) to a cell using an electromagnet to apply a magnetic force so as to tend to move particles towards magnet and at the same time moving the magnet
11/20/2008US20080286360 Chemically patterned hydrogels, manufacture and use thereof
11/20/2008US20080286359 sodium risedronate, disodium ethylenediaminetetraacetic acid, citric acid or sodium hexametaphosphate as chelating agent for immediate release of risedronate and the chelating agent to the small intestine of the mammal and absorption of risedronate when administered with or without food and beverages
11/20/2008US20080286358 a nutraceutical tablet form for waking up energized in the morning containing an active ingredients adapted so that the user will wake up energized and refreshed, selected form thiamin, riboflavin, Niacin, B6, B12, eleuthero root extract, guarana seed extract and L-Tyrosine and a time release coating
11/20/2008US20080286357 Multi-functional particulate delivery system for pharmacologically active ingredients
11/20/2008US20080286356 Pharmaceutical compositions containing terbinafin and use thereof
11/20/2008US20080286355 inhibitor of serine proteases(e.g.serpins, aprotinin, N-tosyl-L-phenylalanyl chloromethyl ketone, dichloroisocoumarin, nexin-1, AEBSF-HCl, Antipain, benzamidine, leupeptin, ovomucoid) ; amastatin, arphamenin, bestatin, diprotin A as metalloprotease inhibitor; irritable bowl syndrome; hyperalgesia
11/20/2008US20080286354 administering a bile acid e.g ursodiol, ursodiol bicarbonate and ursodiol sulfate, a fibrate e.g. bezafibrate, fenofibrate, gemfibrozil, ciprofibrate and derivatives of 2-phenoxy-2-methylpropanoic acid, and a statin e.g. simvastatin, fluvastatin, pravastatin, atorvastatin to treat chronic hepatitis
11/20/2008US20080286353 Cationic liposomes containing immune response generating moieties
11/20/2008US20080286352 Liposome Compositions
11/20/2008US20080286351 Pegylated Cardiolipin Analogs, Methods of Synthesis, and Uses Thereof
11/20/2008US20080286350 Formulation of Multivalent Antibody Constructs and Use of Same for Cancer Therapy
11/20/2008US20080286349 Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
11/20/2008US20080286348 Secured transdermal delivery system
11/20/2008US20080286346 Wound Dressing
11/20/2008US20080286345 Modified multilayered film
11/20/2008US20080286344 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients
11/20/2008US20080286343 Solid form
11/20/2008US20080286342 Form of Administration Based on Crosslinked Hydrophilic Polymers
11/20/2008US20080286341 Oral drug delivery; Arginine, Aspargine, Glutamic acid, Glutamine buffer coating buffer; nicotine, cyclodextrin complex core; polyacrylate cation exchanger; lozenges, tablets; reduce the urge to smoke
11/20/2008US20080286340 Oral drug delivery; Arginine, Aspargine, Glutamic acid, Glutamine buffer coating buffer; nicotine, cyclodextrin complex core; polyacrylate cation exchanger; lozenges, tablets; reduce the urge to smoke
11/20/2008US20080286339 Using multi-segment device to deliver selective androgen and estrogen receptor modulators to women in order to relieve symptoms associated with menopause
11/20/2008US20080286338 Drug delivery system with scleral lens
11/20/2008US20080286337 Method of treating a disease in an eye using a scleral lens
11/20/2008US20080286336 Bioerodible poly lactic co glycolic acid copolymer eye implant with active agents blended in; Risperidone; glaucoma
11/20/2008US20080286334 Poly lactic co-glycolic acid copolymer biodegradable polymer matrix; eye implant infused with ace-inhibitors, endogenous cytokines, agents that influence basement membrane, agents that influence the growth of endothelial cells, adrenergic agonists or blockers; uveitis, macular edema, macular degeneration
11/20/2008US20080286332 Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties
11/20/2008US20080286329 Blood-derived plastic bone tissue articles; Young's Modulus of 0.03 GPa to 50 GPa; article; biological response modifiers hormones, growth factors, cytokines, extracellular matrix molecules; crosslinking agents iridoid derivatives, diimidates, diones; plasticizers phthalate, adipate, plant oils, glycols
11/20/2008US20080286327 Thombolysis and chronic anticoagulation therapy
11/20/2008US20080286325 Cyclodextrin elution media for medical device coatings comprising a taxane therapeutic agent
11/20/2008US20080286324 Media and devices for cold storage of therapeutic cells
11/20/2008US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor
11/20/2008US20080286322 Methods and devices for the sustained release of multiple drugs
11/20/2008US20080286318 Polymeric microparticle delivery system to extend the delivery of oral care compounds; storage stability;
11/20/2008US20080286304 Use of pre-viral DNA replication enveloped particles (PREPS) and/or L-particles for manufacture of a medicament for regulating leukocyte function; Cytotoxic T Lymphocytes
11/20/2008US20080286280 Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies
11/20/2008US20080286270 Stabilized liquid anti-RSV antibody formulations
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286253 Composition Comprising Polymeric Material And Uses Thereof
11/20/2008US20080286244 Bio-Artificial Materials with Tuneable Properties
11/20/2008US20080286211 Treating pain associated with epithelial lesions and disorders of impaired mucin function using a pharmaceutical composition containing mucin glycoproteins in combination with therapeutic agents, e.g., trefoil polypeptides
11/20/2008US20080286210 Novel antimicrobial peptides
11/20/2008US20080286209 Comprising isoprenoid-based compounds (e.g., farnesol and/or farnesol analogues or derivatives) or dehydroisoprenoid-based compounds, for use in treating (e.g., suppressing) alcohol withdrawal syndrome and associated neurological symptoms (e.g., depression, tremor, anxiety)
11/20/2008US20080286206 Composition and Method for Medical Imaging of Body Cavities
11/20/2008DE102007023491A1 Nanoscale hollow spheres having a specific range of outer diameter, inner diameter and wall thickness, useful as building material, filling material or construction material, as a radiopaque material in the ultrasound investigations
11/20/2008CA2756796A1 Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
11/20/2008CA2687085A1 Anti-insomnia compositions and methods
11/20/2008CA2687019A1 Pharmaceutical composition comprising desloratadine
11/20/2008CA2686765A1 Aqueous pharmaceutical composition
11/20/2008CA2686756A1 Pharmaceutical compositions for poorly soluble drugs
11/20/2008CA2686563A1 Lung volume reduction therapy using crosslinked non-natural polymers
11/20/2008CA2686511A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008CA2686505A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008CA2686035A1 Robust rapid disintegration tablet formulation
11/20/2008CA2685745A1 Water dispersible polymer compositions
1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 2991